申请人:Imperial Chemical Industries Limited
公开号:US04096337A1
公开(公告)日:1978-06-20
The disclosure relates to novel 15-(3-aryl- or 3-aralkyl-cyclobutyl, -cyclopentyl and -cyclohexyl)-.omega.-pentanor prostaglandin analogues, for example 9.alpha.,11.alpha.,15.alpha.-trihydroxy-15-(trans-3-phenylcyclobutyl)-16,1 7,18,19,20-pentanor-5-cis,13-trans-prostadienoic acid, to pharmaceutical or veterinary compositions containing such a compound, and to a method of inducing luteolysis in animals by orally administering such a compound.
该公开涉及一种新型的15-(3-芳基或3-芳基烷基环丁基、环戊基和环己基)-ω-戊烯基前列腺素类似物,例如9α,11α,15α-三羟基-15-(反-3-苯基环丁基)-16,17,18,19,20-戊烯-5-顺,13-反-前列腺二烯酸,以及含有该化合物的制药或兽医组合物,以及通过口服该化合物诱导动物黄体破裂的方法。